ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

INAB Company Profile and Key Details

NASDAQ : INAB

IN8bio, Inc.

$0.23

-0.0151-6.07%

Open: 12:52 PM

55.85

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

INAB Stock Price Chart

Stock Price Today

IN8bio, Inc. (INAB) stock declined over -6.07%, trading at $0.23 on NASDAQ, down from the previous close of $0.25. The stock opened at $0.25, fluctuating between $0.23 and $0.25 in the recent session.

Stock Snapshot

0.2488

Prev. Close

0.25

Open

18.99M

Market Cap

81.26M

Number of Shares

0.2273

Day Low

0.2525

Day High

-0.32

P/E Ratio

79.65%

Free Float in %

-0.74

EPS (TTM)

0.7

Book Value

-0.67

Cash Flow per Share

798.19K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 12, 2025	0.24	0.25	0.24	0.25	861.67K
Mar 11, 2025	0.24	0.25	0.23	0.24	1.73M
Mar 10, 2025	0.26	0.26	0.24	0.25	1.53M
Mar 07, 2025	0.25	0.25	0.24	0.25	1.38M
Mar 06, 2025	0.26	0.27	0.26	0.26	1.04M
Mar 05, 2025	0.25	0.27	0.25	0.27	1.32M
Mar 04, 2025	0.25	0.26	0.23	0.26	1.79M
Mar 03, 2025	0.28	0.29	0.25	0.26	3.55M
Feb 28, 2025	0.25	0.27	0.25	0.27	2.85M
Feb 27, 2025	0.27	0.27	0.25	0.25	1.25M
Feb 26, 2025	0.25	0.27	0.25	0.27	902.21K
Feb 25, 2025	0.28	0.28	0.25	0.26	1.44M
Feb 24, 2025	0.28	0.29	0.27	0.27	1.67M
Feb 21, 2025	0.28	0.29	0.26	0.27	2.17M
Feb 20, 2025	0.28	0.30	0.27	0.29	3.47M
Feb 19, 2025	0.27	0.30	0.26	0.29	4.63M
Feb 18, 2025	0.28	0.28	0.25	0.27	6.17M
Feb 14, 2025	0.31	0.33	0.29	0.29	8.37M
Feb 13, 2025	0.32	0.33	0.29	0.32	13.45M
Feb 12, 2025	0.28	0.32	0.26	0.29	11.88M

Contact Details

New York, NY 10118

United States

Website: https://in8bio.comContact: 646 600 6438

About Company

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current IN8bio, Inc. (INAB) stock price?

IN8bio, Inc. (NASDAQ: INAB) stock price is $0.23 in the last trading session. During the trading session, INAB stock reached the peak price of $0.25 while $0.23 was the lowest point it dropped to. The percentage change in INAB stock occurred in the recent session was -6.07% while the dollar amount for the price change in INAB stock was -$0.02.

INAB's industry and sector of operation?

The NASDAQ listed INAB is part of Biotechnology industry that operates in the broader Healthcare sector. IN8bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INAB?

Mr. Patrick McCall CPA
Chief Financial Officer & Sec.
Mr. William Ho
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Kenneth R. LaMontagne Ph.D.
Senior Vice President of Bus. Devel.
Mr. Tai-Wei Ho
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Kate Rochlin Ph.D.
Chief Operating Officer
Dr. Trishna Goswami M.D.
Chief Medical Officer
Dr. Lawrence S. Lamb Ph.D.
Executive Vice President, Co-Founder & Chief Scientific Officer

How INAB did perform over past 52-week?

INAB's closing price is 14.65% higher than its 52-week low of $0.22 where as its distance from 52-week high of $1.74 is -85.7%.

How many employees does INAB have?

Number of INAB employees currently stands at 18.

Link for INAB official website?

Official Website of INAB is: https://in8bio.com

How do I contact INAB?

INAB could be contacted at phone 646 600 6438 and can also be accessed through its website. INAB operates from 350 5th Avenue, New York, NY 10118, United States.

How many shares of INAB are traded daily?

INAB stock volume for the day was 798.19K shares. The average number of INAB shares traded daily for last 3 months was 5.62M.

What is the market cap of INAB currently?

The market value of INAB currently stands at $18.99M with its latest stock price at $0.23 and 81.26M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	18
Beta	0.03
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology